Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922 · see citing works

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,953 · see citing works

Guide to receptors and channels (GRAC), 5th edition

Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947 · see citing works

The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats

Grill, H. J., & Norgren, R. (1978) · Brain Research · doi:10.1016/0006-8993(78)90568-1 · Cited by 1,203 · see citing works

G Protein-Coupled Receptor Allosterism and Complexing

Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 934 · see citing works

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878 · see citing works

Cannabidiol and (−)Δ ⁹ -tetrahydrocannabinol are neuroprotective antioxidants

Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850 · see citing works

Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro

Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763 · see citing works

Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat

Cechetto, D. F., & Saper, C. B. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902620104 · Cited by 703 · see citing works

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669 · see citing works

History of Cannabis and Its Preparations in Saga, Science, and Sobriquet

Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 630 · see citing works

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

Forster, E. A., Cliffe, I. A., Bill, D. J., Dover, G. M., Jones, D., Reilly, Y., & Fletcher, A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00234-c · Cited by 614 · see citing works

THE INSULA: FURTHER OBSERVATIONS ON ITS FUNCTION

PENFIELD, W., & FAULK, M. E. (1955) · Brain · doi:10.1093/brain/78.4.445 · Cited by 606 · see citing works

Somato-motor, autonomic and electrocorticographic responses to electrical stimulation of rhinencephalic and other structures in primates, cat, and dog; a study of responses from the limbic, subcallosal, orbito-insular, piriform and temporal cortex, hippocampus-fornix and amygdala.

Kaada, B. R. (1951) · PubMed · Cited by 549 · see citing works

Cannabidiol—recent advances

Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · see citing works

Guide to Receptors and Channels (GRAC), 3rd edition

Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707746 · Cited by 510 · see citing works

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression

Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497 · see citing works

Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain

Blier, P. U., & de Montigny, C. (1987) · Synapse · doi:10.1002/syn.890010511 · Cited by 426 · see citing works

Chronically Decerebrate Rats Demonstrate Satiation But Not Bait Shyness

Grill, H. J., & Norgren, R. (1978) · Science · doi:10.1126/science.663655 · Cited by 423 · see citing works

Allosteric Modulation of the Cannabinoid CB1 Receptor

Price, M. R., Baillie, G. L., Thomas, A., Stevenson, L. A., Easson, M., Goodwin, R., Mclean, A., McIntosh, L., Goodwin, G., Walker, G., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016162 · Cited by 418 · see citing works

Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630

Ross, R. A., Brockie, H. C., Stevenson, L., Murphy, V. L., Templeton, F., Makriyannis, A., & Pertwee, R. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702351 · Cited by 407 · see citing works

Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype

Vergé, D., Daval, G., Patey, A., GOZLAN, H., Mestikawy, S. E., & Hamon, M. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90099-8 · Cited by 385 · see citing works

Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT_1Areceptors

Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366 · see citing works

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364 · see citing works

Inactivation of the Interoceptive Insula Disrupts Drug Craving and Malaise Induced by Lithium

Contreras, M., Ceric, F., & Torrealba, F. (2007) · Science · doi:10.1126/science.1145590 · Cited by 297 · see citing works

Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei

Sotelo, C., Cholley, B., Mestikawy, S. E., GOZLAN, H., & Hamon, M. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00026.x · Cited by 285 · see citing works

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects

Mechoulam, R., & Hanuš, L. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00144-5 · Cited by 250 · see citing works

Taste avoidance and taste aversion: Evidence for two different processes

Parker, L. A. (2003) · Learning & Behavior · doi:10.3758/bf03195979 · Cited by 239 · see citing works

Current Protocols in Pharmacology

(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471141755 · Cited by 237 · see citing works

Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret

Sepers, M. D., Oland, L. D., Ho, W., Hillard, C. J., Mackie, K., Davison, J. S., & Sharkey, K. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.28466 · Cited by 233 · see citing works

Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine 1A Receptor–Dependent Mechanism

Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., & Fujiwara, M. (2005) · Stroke · doi:10.1161/01.str.0000163083.59201.34 · Cited by 225 · see citing works

Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances

Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V., & Hurd, Y. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4291-09.2009 · Cited by 210 · see citing works

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174 · see citing works

Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats

Kim‐Mitsuyama, S., Yamamoto, E., Tanaka, T., Zhan, Y., Izumi, Y., Izumiya, Y., Ioroi, T., Wanibuchi, H., & Iwao, H. (2005) · Stroke · doi:10.1161/01.str.0000163084.16505.e3 · Cited by 173 · see citing works

Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat.

Travers, J. B., & Norgren, R. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.4.544 · Cited by 157 · see citing works

(−)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens

Pertwee, R. G., Ross, R. A., Craib, S. J., & Thomas, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02624-9 · Cited by 156 · see citing works

Electromyographic analysis of the ingestion and rejection of sapid stimuli in the rat.

Travers, J. B., & Norgren, R. (1986) · Behavioral Neuroscience · doi:10.1037//0735-7044.100.4.544 · Cited by 152 · see citing works

Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)

Parker, L. A., Kwiatkowska, M., Burton, P., & Mechoulam, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1571-2 · Cited by 146 · see citing works

A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew)

Kwiatkowska, M., Parker, L., Burton, P., & Mechoulam, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1739-9 · Cited by 131 · see citing works

Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation

Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00589.x · Cited by 121 · see citing works

Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew

Darmani, N. A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00531-7 · Cited by 103 · see citing works

Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats

Parker, L. A., Mechoulam, R., & Schlievert, C. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00006 · Cited by 103 · see citing works

The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes

Yang, K. S., Galadari, S., Isaev, D. S., Petroianu, G. A., Shippenberg, T. S., & Öz, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162594 · Cited by 91 · see citing works

Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance

Hayakawa, K., Mishima, K., Nozako, M., Ogata, A., Hazekawa, M., Liu, A.-X., Fujioka, M., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.11.005 · Cited by 89 · see citing works

Taste avoidance, but not aversion, learning in rats lacking gustatory cortex.

Kiefer, S. W., & Orr, M. R. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.1.140 · Cited by 89 · see citing works

Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea

Parker, L. A., Mechoulam, R., Schlievert, C., Abbott, L., Fudge, M. A., & Burton, P. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1329-2 · Cited by 89 · see citing works

The role of the anterior insular cortex in ictal vomiting: A stereotactic electroencephalography study

Catenoix, H., Isnard, J., Guénot, M., Petit, J., Rémy, C., & Mauguı̀ere, F. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.06.019 · Cited by 89 · see citing works

The antiemetic drug ondansetron intereferes with lithium-induced conditioned rejection reactions, but not lithium induced taste avoidance in rats.

Limebeer, C. L., & Parker, L. A. (2000) · Journal of Experimental Psychology Animal Behavior Processes · doi:10.1037//0097-7403.26.4.371 · Cited by 87 · see citing works

Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism

Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04565.x · Cited by 84 · see citing works

Antiemetic Effects of Serotonergic 5-HT1A-Receptor Agonists in Suncus Murinus

Okada, F., Torii, Y., Saitō, H., & Matsuki, N. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.64.109 · Cited by 77 · see citing works

Taste avoidance, but not aversion, learning in rats lacking gustatory cortex.

Kiefer, S. W., & Orr, M. R. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.1.140 · Cited by 77 · see citing works

8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine

Lucot, J. B., & Crampton, G. H. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90399-7 · Cited by 76 · see citing works

The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat

Rock, E. M., Limebeer, C. L., Mechoulam, R., Piomelli, D., & Parker, L. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0970-1 · Cited by 74 · see citing works

Conditioned nausea in rats: Assessment by conditioned disgust reactions, rather than conditioned taste avoidance.

Parker, L. A., Rana, S. A., & Limebeer, C. L. (2008) · Canadian Journal of Experimental Psychology/Revue canadienne de psychologie expérimentale · doi:10.1037/a0012531 · Cited by 72 · see citing works

The antiemetic drug ondansetron intereferes with lithium-induced conditioned rejection reactions, but not lithium induced taste avoidance in rats.

Limebeer, C. L., & Parker, L. A. (2000) · Journal of Experimental Psychology Animal Behavior Processes · doi:10.1037/0097-7403.26.4.371 · Cited by 69 · see citing works

Agonist and Antagonist Actions of (-)Pindolol at Recombinant, Human Serotonin1A (5-HT1A) Receptors

Newman‐Tancredi, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00169-3 · Cited by 65 · see citing works

Behavioral conditioned responses across multiple conditioning/testing trials elicited by lithium- and amphetamine-paired flavors

Parker, L. A. (1984) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(84)90569-7 · Cited by 62 · see citing works

The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew)

Parker, L. A., Limebeer, C. L., Rock, E. M., Litt, D., Kwiatkowska, M., & Piomelli, D. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.014 · Cited by 62 · see citing works

Inverse agonism of cannabinoid CB1 receptors potentiates LiCl‐induced nausea in the conditioned gaping model in rats

Limebeer, C. L., Vemuri, K. V., Bedard, H., Lang, S., Ossenkopp, K., Makriyannis, A., & Parker, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00885.x · Cited by 62 · see citing works

Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism

Hayakawa, K., Mishima, K., Abe, K., Hasebe, N., Takamatsu, F., Yasuda, H., Ikeda, T., Inui, K., Egashira, N., Iwasaki, K., et al. (2004) · Neuroreport · doi:10.1097/00001756-200410250-00016 · Cited by 56 · see citing works

The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus

Andrews, P. L. R., Torii, Y., Saito, H., & Matsuki, N. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00275-0 · Cited by 55 · see citing works

Allosteric modulation of 5-HT1A receptors by zinc: Binding studies

Barrondo, S., & Sallés, J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.018 · Cited by 54 · see citing works

The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent.

Murillo‐Rodríguez, E., Millán‐Aldaco, D., Palomero‐Rivero, M., Mechoulam, R., & Drucker-Colı́n, R. (2008) · Behavioral Neuroscience · doi:10.1037/a0013278 · Cited by 45 · see citing works

The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats

Limebeer, C. L., & Parker, L. A. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1309-6 · Cited by 45 · see citing works

Quantification of Allosteric Interactions at G Protein–Coupled Receptors Using Radioligand Binding Assays

Leach, K., Sexton, P. M., & Christopoulos, A. (2011) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0122s52 · Cited by 39 · see citing works

The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis in<i>Suncus murinus</i>

Cluny, N. L., Naylor, R. J., Whittle, B. A., & Javid, F. A. (2008) · Basic &amp; Clinical Pharmacology &amp; Toxicology · doi:10.1111/j.1742-7843.2008.00253.x · Cited by 39 · see citing works

Receptor mechanism and antiemetic activity of structurally‐diverse cannabinoids against radiation‐induced emesis in the least shrew

Darmani, N. A., Janoyan, J. J., Crim, J. L., & Ramirez, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.093 · Cited by 38 · see citing works

5,7-Dihydroxytryptamine Lesions of the Dorsal and Median Raphe Nuclei Interfere With Lithium-Induced Conditioned Gaping, but Not Conditioned Taste Avoidance, in Rats.

Limebeer, C. L., Parker, L. A., & Fletcher, P. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.6.1391 · Cited by 38 · see citing works

Antiemetic effects of 5-HT1A agonists in the pigeon

Wolff, M. C., & Leander, J. D. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90438-3 · Cited by 31 · see citing works

Differential effects of neurotoxin-induced lesions of the basolateral amygdala and central nucleus of the amygdala on lithium-induced conditioned disgust reactions and conditioned taste avoidance

Rana, S. A., & Parker, L. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.01.005 · Cited by 29 · see citing works

Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY100635 into the dorsal and median raphe nuclei of the rat

Herges, S., & TAYLOR, D. A. H. B. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900058 · Cited by 27 · see citing works

The effect of the 5-HT1A receptor agonist, 8-OH-DPAT, on motion-induced emesis in Suncus murinus

Javid, F. A., & Naylor, R. J. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.11.018 · Cited by 21 · see citing works

Effect of 5-HT3 antagonists and a 5-HT1A agonist on fluoxetine-induced conditioned gaping reactions in rats

Limebeer, C. L., Litt, D. E., & Parker, L. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1421-3 · Cited by 18 · see citing works

[3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.

Carli, M., Afkhami-Dastjerdian, S., & Reader, T. A. (1996) · PubMed · Cited by 16 · see citing works

Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs.

Yk, G., & Ss, S. (2002) · PubMed · Cited by 10 · see citing works

Cannabinoids in the Management of Nausea and Vomiting

Parker, L. A., & Limebeer, C. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_13 · Cited by 8 · see citing works

The pharmacokinetics and the pharmacodynamics of cannabinoids

Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724 · see citing works

Cannabidiol as a Potential Treatment for Anxiety Disorders

Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 717 · see citing works

Molecular Targets of the Phytocannabinoids: A Complex Picture

Morales, P., Hurst, D. P., & Reggio, P. H. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_4 · Cited by 488 · see citing works

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 482 · see citing works

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works

Cannabidiol, neuroprotection and neuropsychiatric disorders

Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446 · see citing works

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain

Gregorio, D. D., McLaughlin, R. J., Posa, L., Ochoa‐Sanchez, R., Enns, J. P., López-Canul, M., Aboud, M. K., Maione, S., Comai, S., & Gobbi, G. (2018) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 402 · see citing works

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández‐Ruíz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R. G., Mechoulam, R., & Martínez-Orgado, J. A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04341.x · Cited by 356 · see citing works

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306 · see citing works

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action

Mlost, J., Bryk, M., & Starowicz, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228870 · Cited by 300 · see citing works

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00259 · Cited by 294 · see citing works

A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)

Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 291 · see citing works

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors

Linge, R., Jiménez-Sánchez, L., Campa, L., Pilar-Cuéllar, F., Vidal, R., Pazos, Á., Adell, A., & Díaz, Á. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.017 · Cited by 285 · see citing works

Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users

Bonn-Miller, M. O., Boden, M. T., Bucossi, M. M., & Babson, K. A. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.821477 · Cited by 281 · see citing works

Molecular Pharmacology of Phytocannabinoids

Turner, S. E., Williams, C. M., Iversen, L. L., & Whalley, B. J. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_3 · Cited by 246 · see citing works

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder

Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.162 · Cited by 239 · see citing works

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works

Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

Pazos, M. R., Mohammed, N., Lafuente, H., Santos, M., Martínez‐Pinilla, E., Moreno, E., Valdizán, E. M., Romero, J., Pazos, Á., Franco, R., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.027 · Cited by 223 · see citing works

The Pharmacological Case for Cannabigerol

Nachnani, R., Raup‐Konsavage, W. M., & Vrana, K. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000340 · Cited by 214 · see citing works

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

Fogaça, M. V., Campos, A. C., Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.001 · Cited by 208 · see citing works

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Martínez‐Pinilla, E., Varani, K., Reyes‐Resina, I., Angelats, E., Vincenzi, F., Ferreiro‐Vera, C., Oyarzábal, J., Canela, E. I., Lanciego, J. L., Nadal, X., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00744 · Cited by 200 · see citing works

Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system

Sharkey, K. A., Darmani, N. A., & Parker, L. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.068 · Cited by 195 · see citing works

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol

Morales, P., Reggio, P. H., & Jagerovic, N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00422 · Cited by 181 · see citing works

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175 · see citing works

Beyond THC and Endocannabinoids

Pacher, P., Kogan, N. M., & Mechoulam, R. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021441 · Cited by 175 · see citing works

Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death

Rimmerman, N., Ben-Hail, D., Porat, Z., Juknat, A., Kozela, E., Daniels, M. P., Connelly, P. S., Leishman, E., Bradshaw, H. B., Shoshan‐Barmatz, V., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.471 · Cited by 164 · see citing works

The Polypharmacological Effects of Cannabidiol

Castillo-Arellano, J. I., Canseco-Alba, A., Cutler, S. J., & León, F. (2023) · Molecules · doi:10.3390/molecules28073271 · Cited by 163 · see citing works

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Peres, F. F., Lima, A. C., Hallak, J. E. C., Crippa, J. A. S., Silva, R. H., & Abílio, V. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00482 · Cited by 160 · see citing works

Constituents of Cannabis Sativa

Rock, E. M., & Parker, L. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_1 · Cited by 158 · see citing works

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors

Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.033 · Cited by 156 · see citing works

Cannabidiolic acid prevents vomiting in <i><scp>S</scp>uncus murinus</i> and nausea‐induced behaviour in rats by enhancing 5‐<scp>HT_1A</scp> receptor activation

Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., Stott, C., Javid, F., Parker, L., & Pertwee, R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12043 · Cited by 151 · see citing works

Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer

Kis, B., Ifrim, F. C., Buda, V. O., Avram, Ș., Pavel, I. Z., Antal, D., Păunescu, V., Dehelean, C. A., Ardelean, F., Diaconeasa, Z. M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235905 · Cited by 148 · see citing works

Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation

Kopustinskienė, D. M., Masteiková, R., Lažauskas, R., & Bernatonienė, J. (2022) · Antioxidants · doi:10.3390/antiox11040660 · Cited by 141 · see citing works

Conditioned flavor avoidance and conditioned gaping: Rat models of conditioned nausea

Parker, L. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.070 · Cited by 140 · see citing works

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors

Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139 · see citing works

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease

Patricio, F., Morales-Andrade, A. A., Patricio-Martínez, A., & Limón, I. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595635 · Cited by 129 · see citing works

The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease

Hasenoehrl, C., Taschler, U., Storr, M., & Schicho, R. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12931 · Cited by 120 · see citing works

Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels

Sales, A. J., Crestani, C. C., Guimarães, F. S., & Joca, S. R. L. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.002 · Cited by 118 · see citing works

Endocannabinoids: A unique opportunity to develop multitarget analgesics

Maione, S., Costa, B., & Marzo, V. D. (2013) · Pain · doi:10.1016/j.pain.2013.03.023 · Cited by 102 · see citing works

Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

Turna, J., Patterson, B. A., & Ameringen, M. V. (2017) · Depression and Anxiety · doi:10.1002/da.22664 · Cited by 101 · see citing works

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1activation

Stanley, C. P., Hind, W. H., Tufarelli, C., & O’Sullivan, S. E. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv179 · Cited by 100 · see citing works

Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials

de Bitencourt, R. M., & Takahashi, R. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00502 · Cited by 98 · see citing works

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence

Rohleder, C., Müller, J. K., Lange, B., & Leweke, F. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00422 · Cited by 94 · see citing works

Therapeutic Potential of Cannabinoids in Psychosis

Leweke, F. M., Mueller, J. K., Lange, B., & Rohleder, C. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.018 · Cited by 92 · see citing works

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease

Silvestro, S., Schepici, G., Bramanti, P., & Mazzon, E. (2020) · Molecules · doi:10.3390/molecules25215186 · Cited by 90 · see citing works

The Pharmacology and Therapeutic Potential of Plant Cannabinoids

Cascio, M. G., Pertwee, R. G., & Marini, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-54564-6_9 · Cited by 88 · see citing works

Endocannabinoids, cannabinoids and the regulation of anxiety

Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 85 · see citing works

Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness

Hillard, C. J., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 79 · see citing works

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 79 · see citing works

The evolving science of phytocannabinoids

Reekie, T. A., Scott, M., & Kassiou, M. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0101 · Cited by 77 · see citing works

Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors

Espejo‐Porras, F., Fernández‐Ruíz, J., Pertwee, R. G., Mechoulam, R., & García, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.024 · Cited by 75 · see citing works

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets

Vitale, R. M., Iannotti, F. A., & Amodeo, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094876 · Cited by 74 · see citing works

Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice

Gomes, F. V., Bel, E. A. D., & Guimarães, F. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.005 · Cited by 74 · see citing works

Pharmacological effects of cannabidiol by transient receptor potential channels

Etemad, L., Karimi, G., Alavi, M. S., & Roohbakhsh, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120582 · Cited by 73 · see citing works

(‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research

Formato, M., Crescente, G., Scognamiglio, M., Fiorentino, A., Pecoraro, M. T., Piccolella, S., Catauro, M., & Pacifico, S. (2020) · Molecules · doi:10.3390/molecules25112638 · Cited by 72 · see citing works

Biosynthesis and synthetic biology of psychoactive natural products

Jamieson, C. S., Misa, J., Tang, Y., & Billingsley, J. M. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00065a · Cited by 71 · see citing works

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

Hasbi, A., Madras, B. K., & George, S. R. (2023) · Brain Sciences · doi:10.3390/brainsci13020325 · Cited by 68 · see citing works

The phytocannabinoid, Δ9‐tetrahydrocannabivarin, can act through 5‐ HT 1 A receptors to produce antipsychotic effects

Cascio, M. G., Zamberletti, E., Marini, P., Parolaro, D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13000 · Cited by 67 · see citing works

Looking beyond 5-HT3 receptors: A review of the wider role of serotonin in the pharmacology of nausea and vomiting

Johnston, K. D., Lu, Z., & Rudd, J. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.014 · Cited by 67 · see citing works

Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects

Mendiguren, A., Aostri, E., & Pineda, J. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.029 · Cited by 66 · see citing works

Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

Pertwee, R. G., Rock, E. M., Guenther, K. G., Limebeer, C. L., Stevenson, L., Haj, C. G., Smoum, R., Parker, L. A., & Mechoulam, R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14073 · Cited by 66 · see citing works

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

Campos, A. C., de Paula Soares, V., Carvalho, M. C., Ferreira, F. R., Vicente, M. A., Brandão, M. L., Zuardi, A. W., Zangrossi, H., & Guimarães, F. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2878-7 · Cited by 65 · see citing works

Tetrahydrocannabinolic acid reduces nausea‐induced conditioned gaping in rats and vomiting in S uncus murinus

Rock, E. M., Kopstick, R. L., Limebeer, C. L., & Parker, L. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12316 · Cited by 65 · see citing works

Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

Christensen, C., Rose, M., Cornett, C., & Allesø, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082323 · Cited by 63 · see citing works

The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility

Abalo, R., Vera, G., López-Pérez, A. E., Martínez-Villaluenga, M., & Martı́n, M. I. (2012) · Pharmacology · doi:10.1159/000339072 · Cited by 63 · see citing works

Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study

Devinsky, O., Kraft, K. S., Rusch, L. M., Fein, M., & Leone‐Bay, A. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.08.012 · Cited by 62 · see citing works

The use of cannabis in supportive care and treatment of brain tumor

Likar, R., & Nahler, G. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npw027 · Cited by 61 · see citing works

Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice

Sonego, A. B., Gomes, F. V., Bel, E. A. D., & Guimarães, F. S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.042 · Cited by 61 · see citing works

A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors

Echeverry, C., Prunell, G., Narbondo, C., de Medina, V. S., Nadal, X., Reyes-Parada, M. I., & Scorza, C. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00277-y · Cited by 60 · see citing works

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy

Martínez-Aguirre, C., Carmona-Cruz, F., Velasco, A. L., Velasco, F., Aguado-Carrillo, G., Cuéllar‐Herrera, M., & Rocha, L. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.611278 · Cited by 60 · see citing works

Cannabidiol goes nuclear: The role of PPARγ

Khosropoor, S., Alavi, M. S., Etemad, L., & Roohbakhsh, A. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154771 · Cited by 58 · see citing works

Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis.

Han, K., Wang, J.-Y., Wang, P.-Y., & Peng, Y.-C.-H. (2024) · Psychiatry research · doi:10.1016/j.psychres.2024.116049 · Cited by 54 · see citing works

Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice

Karmaus, P. W. F., Wagner, J. G., Harkema, J. R., Kaminski, N. E., & Kaplan, B. L. F. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.741628 · Cited by 54 · see citing works

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats

Genaro, K., Fabris, D., Arantes, A. L. F., Zuardi, A. W., Crippa, J. A. S., & Prado, W. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00391 · Cited by 54 · see citing works

Natural Salicylates and Their Roles in Human Health

Yeasmin, F., & Choi, H. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239049 · Cited by 54 · see citing works

Effect of low doses of cannabidiolic acid and ondansetron on LiCl ‐induced conditioned gaping (a model of nausea‐induced behaviour) in rats

Rock, E., & Parker, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12162 · Cited by 53 · see citing works

The Impact of Cannabidiol on Psychiatric and Medical Conditions

Oberbarnscheidt, T., & Miller, N. S. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4159 · Cited by 53 · see citing works

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

Leweke, F. M., Rohleder, C., Gerth, C. W., Hellmich, M., Pukrop, R., & Koethe, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.614811 · Cited by 52 · see citing works

Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry

Rifkin-Zybutz, R. P., Erridge, S., Holvey, C., Coomber, R., Gaffney, J., Lawn, W., Barros, D. A. R., Bhoskar, U., Mwimba, G., Praveen, K., et al. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06399-3 · Cited by 52 · see citing works

Adverse effects after the use of JWH‐210 – a case series from the EU Spice II plus project

Hermanns‐Clausen, M., Kithinji, J., Spehl, M. S., Angerer, V., Franz, F., Eyer, F., & Auwärter, V. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1936 · Cited by 52 · see citing works

Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System

Schönhofen, P., Bristot, I. J., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018) · CNS Drugs · doi:10.1007/s40263-018-0550-4 · Cited by 51 · see citing works

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain

de Ternay, J., Naassïla, M., Nourredine, M., Louvet, A., Bailly, F., Sescousse, G., Maurage, P., Cottencin, O., Carrieri, P., & Rolland, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00627 · Cited by 51 · see citing works

A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping

Rock, E. M., Limebeer, C. L., Navaratnam, R., Sticht, M. A., Bonner, N., Engeland, K., Downey, R. I., Morris, H. I., Jackson, M., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3498-1 · Cited by 48 · see citing works

Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action

Chaves, Y. C., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00667-3 · Cited by 48 · see citing works

Evidences for the Anti-panic Actions of Cannabidiol

Soares-Rachetti, V. D. P., & Campos, A. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123955 · Cited by 47 · see citing works

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

Leweke, F. M., Mueller, J. K., Lange, B., Fritze, S., Topor, C. E., Koethe, D., & Rohleder, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0539-z · Cited by 47 · see citing works

Cannabinoid pharmacology and therapy in gut disorders

Uranga, J. A., Vera, G., & Abalo, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.048 · Cited by 46 · see citing works

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs

Garcia, G. A., Kube, S. A., Carrera‐Justiz, S., Tittle, D., & Wakshlag, J. J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.939966 · Cited by 45 · see citing works

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting

Rock, E. M., & Parker, L. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00221 · Cited by 45 · see citing works

Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs

Bradley, S., Young, S., Bakke, A. M., Holcombe, L. J., Waller, D., Hunt, A. B. G., Pinfold, K., Watson, P., & Logan, D. W. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.977457 · Cited by 44 · see citing works

Cannabinoids: The Lows and the Highs of Chemotherapy-Induced Nausea and Vomiting

Mortimer, T. L., Mabin, T., & Engelbrecht, A. (2019) · Future Oncology · doi:10.2217/fon-2018-0530 · Cited by 43 · see citing works

Nausea-Induced 5-HT Release in the Interoceptive Insular Cortex and Regulation by Monoacylglycerol Lipase (MAGL) Inhibition and Cannabidiol

Limebeer, C. L., Rock, E. M., Sharkey, K. A., & Parker, L. A. (2018) · eNeuro · doi:10.1523/eneuro.0256-18.2018 · Cited by 42 · see citing works

Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids

Franco, R., Rivas‐Santisteban, R., Reyes‐Resina, I., Casanovas, M., Pérez-Olives, C., Ferreiro‐Vera, C., Navarro, G., de Medina, V. S., & Nadal, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104801 · Cited by 42 · see citing works

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders

Scarante, F. F., Ribeiro, M. A., Almeida-Santos, A. F., Guimarães, F. S., & Campos, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618065 · Cited by 40 · see citing works

Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments

Mori, M., Meyer, E., da Silva, F. F., Milani, H., Guimarães, F. S., & de Oliveira, R. M. W. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15134 · Cited by 40 · see citing works

Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting

Rock, E. M., Limebeer, C. L., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0041 · Cited by 39 · see citing works

Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain

Bernatonienė, J., Ščiupokas, A., Kopustinskienė, D. M., & Petrikonis, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071799 · Cited by 38 · see citing works

Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?

Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 38 · see citing works

Cannabidiol: an alternative therapeutic agent for oral mucositis?

Cuba, L. F., Salum, F. G., Cherubini, K., & de Figueiredo, M. A. Z. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12504 · Cited by 38 · see citing works

Vapor inhalation of cannabidiol (CBD) in rats

Paydar, M. J., Creehan, K. M., Kerr, T. M., & Taffe, M. A. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172741 · Cited by 38 · see citing works

Cannabidiol Indirectly Activates 5-HT1A Somatodendritic Autoreceptors to Attenuate Vomiting and Nausea

Rock, E. M. (2011) · The Atrium (University of Guelph)

Cannabidiolic acid prevents vomiting in <i><scp>S</scp>uncus murinus</i> and nausea‐induced behaviour in rats by enhancing 5‐<scp>HT_1A</scp> receptor activation

Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., Stott, C., Javid, F., Parker, L., & Pertwee, R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12043 · Cited by 151 · see citing works

Cannabidiolic acid enhances 5-HT1A receptor activation and prevents vomiting in Suncus murinus and nausea-like behaviour in rats with greater potency and selectivity than cannabidiol

Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., Stott, C. G., Javid, F. A., Parker, L. A., & Pertwee, R. G. (2013) · University of Huddersfield Repository (University of Huddersfield)

Regulation of nausea and vomiting by cannabinoids

Parker, L. A., Rock, E. M., & Limebeer, C. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01176.x · Cited by 267 · see citing works

Electrophysiological study of the effect of cannabidiol on the dorsal raphe nucleus serotonergic neurons

Aostri, E., Pineda, J., & Mendiguren, A. (2017) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-03-05083